It seems that the stock has changed to become a descending triangle pattern, hopefully, stock may go up tomorrow because of the earnings call, otherwise, we can only wait for good news somewhere in August(according to rumours online)
Do you think today will be the 1 st of breakout downtrend?
Ultracombobreaker
⋅
I'm trapped at 3.74, I freakin hate this stock, I hate it!
Ultracombobreaker
⋅
@Ultracombobreaker, I'm sure this stock will hit three figures, because "thee elite" are investing in it (e.g., Georgey porgy Soros), but for the near future, it's painful! The rumor (I had no input on this) that the company will not announce the FDA approval until late Q3 in order to let people sell in desperation and then soak up the stock below 2 dollars (that's evil if true).
I don't know if that is true or not, but we'll know by April 15th, if they don't announce, then I will say good bye to this stock at any price (phuck em!).
simon0088
⋅
@Ultracombobreaker, I don't think April 15th is a confirmed date. My avg. price is about $2. Over 10k share of it. Haven't sold a share since Jan. Want to see it goes to 15 by the end of 2021. May be a crazy idea. but lets see.
kevinszk
⋅
@simon0088, I hope it won't be pushed below 2 dollars cause it's a good product for the patients, I will hold it strong now.
Ultracombobreaker
⋅
@kevinszk, If this falls below 2 bucks, I'll begrudgingly buy more, but I'll hate every moment of it.
anitas0email
⋅
@Ultracombobreaker, the FDA process has nothing to do with the share price. FDA approval for a device that millions of diabetics may use must go through rigorous investigation before releasing to market. The company can't announce any approval until they have it. The FDA will take as much time as they need to assure a product is safe and effective
Ultracombobreaker
⋅
@anitas0email, I appreciate your insight into the FDA process, but I think you missed the subtext. Please see this post to understand what I mean:
krinxe
⋅
What makes you think it would go to over 15 though? I would like to know ur DD and ur analysis :) @simon0088
Ultracombobreaker
⋅
@krinxe, Once they get 1yr approval from the FDA, this stock will hit triple digits, but who knows when that will be, could be years from now. Their nearest competitor Dexcom is somewhere in the 300's and if their patch (which is painful to insert) falls off, you have to place a completely new patch.